Search results
Why Is Mustang Bio (MBIO) Stock Up 347% Today?
InvestorPlace· 2 days agoThe recent news includes favorable results from the company’s Phase 1/2 clinical trial of MB-106. This is a CD20-targeted, autologous CAR T-cell
Case study reveals important new details about rare second cancers related to CAR-T therapy
Medical Xpress· 7 days agoA new detailed analysis of a patient's second cancer after receiving CAR-T therapy for the initial cancer provides rare but important insights intended to offer helpful guidance ...
New research points to 'stem-like' T cells as culp | Newswise
Newswise· 2 days agoLA JOLLA, CA—Scientists at La Jolla Institute for Immunology (LJI) have shed light on how an unusual population of T cells may drive harmful inflammation in people with ulcerative colitis, an ...
EU regulator mandates label updates on CAR-T cancer therapies
WHTC 1450 Holland· 5 days ago(Reuters) - The European health regulator said on Friday product information for a class of cancer...
Postdoc to investigate molecular mechanisms in the field immune-rejuvenation for drug discovery -...
Nature· 2 days agoIn the compelling and unstoppable research in favor of cellular rejuvenation, Sentcell LTD is looking for PhD or Postdoc Researchers to investigate molecular mechanisms and innovative therapies ...
New blood cancer treatment saving lives, UVM officials say
WCAX-TV Vermont· 22 hours agoUniversity of Vermont Cancer Center officials say a promising treatment for blood cancer launched...
Scientists Uncover Links Between MS and Epstein-Barr Virus | Fox 11 Tri Cities Fox 41 Yakima
FOX 11/41 Yakima· 9 hours agoThe discovery that the Epstein-Barr virus might be a major driver of multiple sclerosis has...
Why Is Penny Stock Mustang Bio Trading Over 190% On Monday? - Mustang Bio (NASDAQ:MBIO)
Benzinga· 2 days agoMonday, the cell therapy-focused company announced that updated data from the ongoing Phase 1/2...
First-in-Disease Use of Kyverna Therapeutics' KYV-101 in Patient With Severe Stiff-Person Syndrome...
Lodi News-Sentinel· 2 days ago"It is extremely encouraging to see this patient improving...
Mustang (MBIO) Soars 477% on Data From Rare Blood Cancer Study
Zacks via Yahoo Finance· 1 day agoUpdated data from a clinical study shows that treatment with Mustang Bio's (MBIO) experimental cell ...